AI Article Synopsis
- Metastasis of differentiated thyroid carcinoma to the pancreas is uncommon, but a case was identified in a man with papillary thyroid carcinoma 7 years post-diagnosis.
- 124I-PET/CT imaging was utilized to confirm the presence of metastatic cancer noninvasively and to help determine the appropriate dosage for 131I treatment.
- This case highlights the growing importance of 124I-PET/CT as a diagnostic and dosimetric tool for personalized therapy in metastatic thyroid cancer patients.
Article Abstract
Metastasis to the pancreas from differentiated thyroid carcinoma is rare. A new pancreatic lesion was identified on surveillance imaging of a man with metastatic papillary thyroid carcinoma 7 years after initial diagnosis. Imaging with 124I-PET/CT was performed to noninvasively confirm metastatic thyroid cancer and provide prospective dosimetry to guide selection of a safe and effective administered activity of 131I. This case demonstrates the emerging role of 124I-PET/CT as a useful diagnostic scan, pretherapy scan, and dosimetric tool to deliver personalized therapy for patients with metastatic thyroid cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/RLU.0000000000003499 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fascial Forearm Free Flap for Large Tracheal Defect Closure.
JAMA Otolaryngol Head Neck Surg
January 2025
Department of Otolaryngology-Head and Neck Surgery, University Hospital of Modena, Modena, Italy.
Primary Leiomyosarcoma of the Thyroid.
Head Neck Pathol
January 2025
Department of medical oncology, Habib Bourguiba Hospital, University of Sfax, Sfax, 3029, Tunisia.
Leiomyosarcoma (LMS) is a malignant mesenchymal neoplasm showing smooth muscle differentiation. Primary LMS of the thyroid gland is quite rare, accounting for only 0.014% of cases.
View Article and Find Full Text PDFCorrection: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.
Cancer Immunol Immunother
January 2025
Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
Plain language summary of a clinical study: anamorelin for treatment of Japanese people with gastrointestinal cancer and cachexia.
Future Oncol
August 2024
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population.
Front Oncol
January 2025
Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Purpose: Studies have shown that gut microbiota is involved in the tumorigenesis and development of prostate cancer. We aimed to perform a comprehensive analysis of causal associations of gut microbiota, metabolites, and cytokines with prostate cancer in the Asian population.
Patients And Methods: Genome-wide association study (GWAS) summary datasets were collected from the public databases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!